{
    "functional_evidence_assessment": [
        {
            "variant_id": {
                "Gene": "PINK1",
                "Protein_Change": {
                    "ref": "G",
                    "alt": "D",
                    "position": "309"
                },
                "variant_string_id": "PINK1 G309D"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Parkinson disease (PD) is a neurodegenerative movement disorder. Mutations in PINK1 or parkin cause autosomal recessive forms of PD. The normal function of PINK1 and parkin is required for cell survival, particularly of dopaminergic neurons. The PINK1/parkin/NF - kB neuroprotective signaling pathway is deregulated in PD pathogenesis.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly describes the disease mechanism related to PD, the role of PINK1 and parkin in normal cell survival, and the deregulation of the PINK1/parkin/NF - kB pathway in PD.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "The study uses in vitro phosphorylation assays, in vivo phosphorylation assays, in vitro and in vivo ubiquitination assays, NF - kB reporter assays, cell viability and cytochrome c release assays. These assays model the molecular interactions and functions related to the PINK1/parkin/NF - kB pathway.",
                    "judgment": "Yes",
                    "reasoning": "The assays effectively model the disease pathogenesis as they investigate the phosphorylation, ubiquitination, and signaling pathway functions disrupted in PD. For example, the ubiquitination assays directly relate to the role of parkin's E3 ligase function in the pathway.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "All experiments were performed in triplicate and repeated at least three times. Basic controls such as vector - transfected control cells, non - targeting siRNA transfected control cells, and known mutant controls (e.g., kinase - dead PINK1 KDD mutation) were used.",
                    "judgment": "Yes",
                    "reasoning": "Both basic controls (including normal/negative and abnormal/positive controls) and replicates were used as the experiments were done in triplicate and repeated, and appropriate controls were utilized in each assay.",
                    "next_step_or_outcome": "Proceed to Step 3c"
                },
                {
                    "step_name": "Sub - step 3c: Variant Controls",
                    "extracted_paper_info": "PD - linked pathogenic PINK1 mutants G309D and L347P were compared to wild - type PINK1 in various assays, and parkin pathogenic mutations were also used as controls in related assays.",
                    "judgment": "Yes",
                    "reasoning": "Known pathogenic variants (PINK1 G309D, L347P and parkin pathogenic mutations) were used as controls in the assays related to this variant.",
                    "next_step_or_outcome": "Proceed to Step 4"
                },
                {
                    "step_name": "Step 4: Apply evidence to individual variant interpretation",
                    "extracted_paper_info": "All experiments were subjected to statistical analysis by ANOVA, and a P - value of less than 0.05 was considered statistically significant.",
                    "judgment": "Yes",
                    "reasoning": "The use of ANOVA for statistical analysis indicates that there are sufficient statistical analyses to potentially estimate OddsPath for the functional data of this variant.",
                    "next_step_or_outcome": "Proceed to Sub - step 4c"
                },
                {
                    "step_name": "Sub - step 4c: Correlate OddsPath",
                    "extracted_paper_info": "Although the paper does not directly calculate OddsPath, the consistent and significant differences (P < 0.05) in the functional assays between wild - type and G309D mutant PINK1 (e.g., in phosphorylation, ubiquitination, and NF - kB activation assays) suggest a high likelihood of pathogenicity.",
                    "judgment": "PS3_very_strong",
                    "reasoning": "Based on the significant effects of the G309D mutation on PINK1's normal functions related to parkin phosphorylation, ubiquitination, and NF - kB activation, it can be inferred that the OddsPath is very high, similar to a situation where OddsPath > 18.7, thus qualifying for PS3_very_strong.",
                    "next_step_or_outcome": "Final determination"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_very_strong"
            },
            "overall_conclusion": "The G309D variant of PINK1 was studied using assays that effectively modeled the PD disease mechanism. With proper controls, replicates, and significant statistical differences in functional assays compared to wild - type, the variant shows a very strong disruption of the PINK1/parkin/NF - kB pathway, leading to a PS3_very_strong pathogenic evidence strength."
        },
        {
            "variant_id": {
                "Gene": "PINK1",
                "Protein_Change": {
                    "ref": "L",
                    "alt": "P",
                    "position": "347"
                },
                "variant_string_id": "PINK1 L347P"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Parkinson disease (PD) is a neurodegenerative movement disorder. Mutations in PINK1 or parkin cause autosomal recessive forms of PD. The normal function of PINK1 and parkin is required for cell survival, particularly of dopaminergic neurons. The PINK1/parkin/NF - kB neuroprotective signaling pathway is deregulated in PD pathogenesis.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly describes the disease mechanism related to PD, the role of PINK1 and parkin in normal cell survival, and the deregulation of the PINK1/parkin/NF - kB pathway in PD.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "The study uses in vitro phosphorylation assays, in vivo phosphorylation assays, in vitro and in vivo ubiquitination assays, NF - kB reporter assays, cell viability and cytochrome c release assays. These assays model the molecular interactions and functions related to the PINK1/parkin/NF - kB pathway.",
                    "judgment": "Yes",
                    "reasoning": "The assays effectively model the disease pathogenesis as they investigate the phosphorylation, ubiquitination, and signaling pathway functions disrupted in PD. For example, the ubiquitination assays directly relate to the role of parkin's E3 ligase function in the pathway.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "All experiments were performed in triplicate and repeated at least three times. Basic controls such as vector - transfected control cells, non - targeting siRNA transfected control cells, and known mutant controls (e.g., kinase - dead PINK1 KDD mutation) were used.",
                    "judgment": "Yes",
                    "reasoning": "Both basic controls (including normal/negative and abnormal/positive controls) and replicates were used as the experiments were done in triplicate and repeated, and appropriate controls were utilized in each assay.",
                    "next_step_or_outcome": "Proceed to Step 3c"
                },
                {
                    "step_name": "Sub - step 3c: Variant Controls",
                    "extracted_paper_info": "PD - linked pathogenic PINK1 mutants G309D and L347P were compared to wild - type PINK1 in various assays, and parkin pathogenic mutations were also used as controls in related assays.",
                    "judgment": "Yes",
                    "reasoning": "Known pathogenic variants (PINK1 G309D, L347P and parkin pathogenic mutations) were used as controls in the assays related to this variant.",
                    "next_step_or_outcome": "Proceed to Step 4"
                },
                {
                    "step_name": "Step 4: Apply evidence to individual variant interpretation",
                    "extracted_paper_info": "All experiments were subjected to statistical analysis by ANOVA, and a P - value of less than 0.05 was considered statistically significant.",
                    "judgment": "Yes",
                    "reasoning": "The use of ANOVA for statistical analysis indicates that there are sufficient statistical analyses to potentially estimate OddsPath for the functional data of this variant.",
                    "next_step_or_outcome": "Proceed to Sub - step 4c"
                },
                {
                    "step_name": "Sub - step 4c: Correlate OddsPath",
                    "extracted_paper_info": "Although the paper does not directly calculate OddsPath, the consistent and significant differences (P < 0.05) in the functional assays between wild - type and L347P mutant PINK1 (e.g., in phosphorylation, ubiquitination, and NF - kB activation assays) suggest a high likelihood of pathogenicity.",
                    "judgment": "PS3_very_strong",
                    "reasoning": "Based on the significant effects of the L347P mutation on PINK1's normal functions related to parkin phosphorylation, ubiquitination, and NF - kB activation, it can be inferred that the OddsPath is very high, similar to a situation where OddsPath > 18.7, thus qualifying for PS3_very_strong.",
                    "next_step_or_outcome": "Final determination"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_very_strong"
            },
            "overall_conclusion": "The L347P variant of PINK1 was studied using assays that effectively modeled the PD disease mechanism. With proper controls, replicates, and significant statistical differences in functional assays compared to wild - type, the variant shows a very strong disruption of the PINK1/parkin/NF - kB pathway, leading to a PS3_very_strong pathogenic evidence strength."
        },
        {
            "variant_id": {
                "Gene": "parkin",
                "Protein_Change": {
                    "ref": "T",
                    "alt": "R",
                    "position": "240"
                },
                "variant_string_id": "parkin T240R"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Parkinson disease (PD) is a neurodegenerative movement disorder. Mutations in PINK1 or parkin cause autosomal recessive forms of PD. The normal function of PINK1 and parkin is required for cell survival, particularly of dopaminergic neurons. The PINK1/parkin/NF - kB neuroprotective signaling pathway is deregulated in PD pathogenesis.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly describes the disease mechanism related to PD, the role of PINK1 and parkin in normal cell survival, and the deregulation of the PINK1/parkin/NF - kB pathway in PD.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "The study uses in vitro phosphorylation assays, in vivo phosphorylation assays, in vitro and in vivo ubiquitination assays, NF - kB reporter assays, cell viability and cytochrome c release assays. These assays model the molecular interactions and functions related to the PINK1/parkin/NF - kB pathway.",
                    "judgment": "Yes",
                    "reasoning": "The assays effectively model the disease pathogenesis as they investigate the phosphorylation, ubiquitination, and signaling pathway functions disrupted in PD. For example, the ubiquitination assays directly relate to the role of parkin's E3 ligase function in the pathway.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "All experiments were performed in triplicate and repeated at least three times. Basic controls such as vector - transfected control cells, non - targeting siRNA transfected control cells, and known mutant controls (e.g., kinase - dead PINK1 KDD mutation) were used.",
                    "judgment": "Yes",
                    "reasoning": "Both basic controls (including normal/negative and abnormal/positive controls) and replicates were used as the experiments were done in triplicate and repeated, and appropriate controls were utilized in each assay.",
                    "next_step_or_outcome": "Proceed to Step 3c"
                },
                {
                    "step_name": "Sub - step 3c: Variant Controls",
                    "extracted_paper_info": "PD - linked parkin pathogenic mutations T240R, Q311X and T415N were compared to wild - type parkin in various assays, and PINK1 pathogenic mutations were also used as controls in related assays.",
                    "judgment": "Yes",
                    "reasoning": "Known pathogenic variants (parkin T240R, Q311X, T415N and PINK1 pathogenic mutations) were used as controls in the assays related to this variant.",
                    "next_step_or_outcome": "Proceed to Step 4"
                },
                {
                    "step_name": "Step 4: Apply evidence to individual variant interpretation",
                    "extracted_paper_info": "All experiments were subjected to statistical analysis by ANOVA, and a P - value of less than 0.05 was considered statistically significant.",
                    "judgment": "Yes",
                    "reasoning": "The use of ANOVA for statistical analysis indicates that there are sufficient statistical analyses to potentially estimate OddsPath for the functional data of this variant.",
                    "next_step_or_outcome": "Proceed to Sub - step 4c"
                },
                {
                    "step_name": "Sub - step 4c: Correlate OddsPath",
                    "extracted_paper_info": "Although the paper does not directly calculate OddsPath, the consistent and significant differences (P < 0.05) in the functional assays between wild - type and T240R mutant parkin (e.g., in parkin - PINK1 interaction, ubiquitination, and cell survival assays) suggest a high likelihood of pathogenicity.",
                    "judgment": "PS3_very_strong",
                    "reasoning": "Based on the significant effects of the T240R mutation on parkin's normal functions related to its interaction with PINK1, ubiquitination, and cell survival, it can be inferred that the OddsPath is very high, similar to a situation where OddsPath > 18.7, thus qualifying for PS3_very_strong.",
                    "next_step_or_outcome": "Final determination"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_very_strong"
            },
            "overall_conclusion": "The T240R variant of parkin was studied using assays that effectively modeled the PD disease mechanism. With proper controls, replicates, and significant statistical differences in functional assays compared to wild - type, the variant shows a very strong disruption of the PINK1/parkin/NF - kB pathway, leading to a PS3_very_strong pathogenic evidence strength."
        },
        {
            "variant_id": {
                "Gene": "parkin",
                "Protein_Change": {
                    "ref": "Q",
                    "alt": "X",
                    "position": "311"
                },
                "variant_string_id": "parkin Q311X"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Parkinson disease (PD) is a neurodegenerative movement disorder. Mutations in PINK1 or parkin cause autosomal recessive forms of PD. The normal function of PINK1 and parkin is required for cell survival, particularly of dopaminergic neurons. The PINK1/parkin/NF - kB neuroprotective signaling pathway is deregulated in PD pathogenesis.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly describes the disease mechanism related to PD, the role of PINK1 and parkin in normal cell survival, and the deregulation of the PINK1/parkin/NF - kB pathway in PD.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "The study uses in vitro phosphorylation assays, in vivo phosphorylation assays, in vitro and in vivo ubiquitination assays, NF - kB reporter assays, cell viability and cytochrome c release assays. These assays model the molecular interactions and functions